Is HIF-PHI the Answer to Tackle ESA Hyporesponsiveness in the Elderly?

Is HIF-PHI the Answer to Tackle ESA Hyporesponsiveness in the Elderly?

Anemia in chronic kidney disease (CKD) has become an important clinical issue with the increased prevalence of elderly patients living with CKD progressing to kidney failure. The causes of anemia in elderly individuals tend to be multifactorial, exacerbated by the physiological effects of aging, fra...

Full description

Bibliographic Details
Main Authors:	Henry H. L. Wu, Rajkumar Chinnadurai, Robert J. Walker
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Kidney and Dialysis
Subjects:	HIF-PHI ESA hyporesponsiveness anemia chronic kidney disease aging multi-morbidities
Online Access:	https://www.mdpi.com/2673-8236/2/3/40

Similar Items

Efficacy of Hypoxia-Inducible Factor Prolyl-Hydroxylase Inhibitors in Renal Anemia: Enhancing Erythropoiesis and Long-Term Outcomes in Patients with Chronic Kidney Disease
by: Yukina Yoshida, et al.
Published: (2024-12-01)

Cardiovascular events by different target hemoglobin levels in ESA-hyporesponsive hemodialysis patients: a multicenter, open-label, randomized controlled study
by: Kosaku Nitta, et al.
Published: (2022-12-01)

Erythrocyte indices and response to hypoxia-inducible factor prolyl hydroxylase inhibitors in chronic kidney disease patients with renal anemia: a retrospective study
by: Kohei Odajima, et al.
Published: (2024-11-01)

A retrospective study on the efficacy of Roxadustat in peritoneal dialysis patients with erythropoietin hyporesponsiveness
by: Jie Liu, et al.
Published: (2024-05-01)

Erythropoietin hyporesponsiveness among egyptian hemodialysis patients
by: Salah Eldin Khedr PhD, et al.
Published: (2017-06-01)

Hyporesponse to statin therapy among patients with acute coronary syndrome: prevalence, impact on the development of heart failure in a short-term follow-up
by: I. V. Druk, et al.
Published: (2022-11-01)

Renal anemia and hyporesponsiveness to ESA for preservation of residual kidney function in patients undergoing peritoneal dialysis
by: Takahiro Imaizumi, et al.
Published: (2025-01-01)

Comparative effectiveness and acceptability of HIF prolyl-hydroxylase inhibitors versus for anemia patients with chronic kidney disease undergoing dialysis: a systematic review and network meta-analysis
by: Qiong Huang, et al.
Published: (2023-07-01)

Roxadustat: Do we know all the answers?
by: Qiu-Yu Li, et al.
Published: (2023-05-01)

Therapeutic Effect of Extracellular Vesicles Derived from HIF Prolyl Hydroxylase Domain Enzyme Inhibitor-Treated Cells on Renal Ischemia/Reperfusion Injury
by: Zhao-Ying Ding, et al.
Published: (2022-03-01)

Severe Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Patients on Chronic Hemodialysis—Reconsidering the Relationship with Thrombo-Inflammation and Oxidative Stress
by: Srdjan Nikolovski, et al.
Published: (2024-10-01)

PRDM1 Drives Human Primary T Cell Hyporesponsiveness by Altering the T Cell Transcriptome and Epigenome
by: Huidong Guo, et al.
Published: (2022-04-01)

Correlation analysis of systemic inflammatory response index with erythropoietin hyporesponsiveness and clinical prognosis in maintenance hemodialysis patients
by: Li Chun-min, et al.
Published: (2025-02-01)

Lower serum magnesium level is an important risk factor for erythropoiesis-stimulating agents hypo-responsiveness in hemodialysis patients
by: Hayam Hebah, et al.
Published: (2025-02-01)

Synergistic deterioration of prognosis associated with decreased grip strength and hyporesponse to erythropoiesis-stimulating agents in patients undergoing hemodialysis
by: Shizuka Kobayashi, et al.
Published: (2022-12-01)

Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia
by: Yifan Zhu, et al.
Published: (2022-07-01)

Prevalence, risk factors, and treatment of anemia in hospitalized older patients across geriatric and nephrological settings in Italy
by: Luca Soraci, et al.
Published: (2024-08-01)

Factors associated with erythropoiesis-stimulating agent hyporesponsiveness anemia in chronic kidney disease patients.
by: Kamalas Amnuay, et al.
Published: (2019-09-01)

Mortality in dialysis patients may not be associated with ESA dose: a 2-year prospective observational study
by: McMahon Lawrence P, et al.
Published: (2012-06-01)

Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease
by: Elisabet Coll, et al.
Published: (2024-11-01)

Activation of Intestinal HIF2α Ameliorates Iron‐Refractory Anemia
by: Yingying Yu, et al.
Published: (2024-03-01)

Endothelial cell-derived SSAO can increase MLC20 phosphorylation in VSMCs
by: Zhang Yuxing, et al.
Published: (2021-10-01)

Comparative Evaluation of GLDAS, ESA CCI SM and SMAP Soil Moisture with in situ Measurements (Case Study: Lorestan Province)
by: Abdolnabi Abdeh kolahchi, et al.
Published: (2023-12-01)

High diagnostic efficiency of IgM-ELISA with the use of multiple antigen peptides (MAP1) from T. gondii ESA (SAG-1, GRA-1 and GRA-7), in acute toxoplasmosis Alta eficiência diagnóstica do IgM ELISA com o uso de múltiplos antígenos peptídicos (MAP1) de T. gondii ESA (SAG-1, GRA-1 e GRA-7) na toxoplasmose aguda
by: Patrícia Regina Barboza Araújo, et al.
Published: (2010-04-01)

Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study
by: Xuejie Zhang, et al.
Published: (2023-11-01)

Portfolio Assessment-Led Engagement, Study and Activation (ESA) Mechanism in Writing Class: Focus on Emotive Dimensions
by: Fatemeh Ranjbarvahed, et al.
Published: (2024-11-01)

Parent and PHY Selection in Slot Bonding IEEE 802.15.4e TSCH Networks
by: Glenn Daneels, et al.
Published: (2021-07-01)

Evaluation of Erythropoietin Stimulating Agent’s Responsiveness and Associated Factors in Hemodialysis Patients with Anemia
by: Salar Ahmed Alzubaidy, et al.
Published: (2024-09-01)

Association of Dialysis Adequacy, Physical and Emotional Symptoms with Erythropoietin-stimulating agent Responsiveness in Iraqi Patients Undergoing Hemodialysis
by: Salar Ahmed, et al.
Published: (2024-01-01)

Daprodustat: A potential game-changer in renal anemia therapy—A perspective
by: Muhammad Usman Haider, et al.
Published: (2023-08-01)

El proyecto PHI. Patrimonio Histórico+cultural Iberoamericano.
by: María Estévez de Gamón, et al.
Published: (2015-12-01)

Pemahaman Nilai Phi (Π) terhadap Rumus Keliling Lingkaran pada Mahasiswa PGSD 2018 Unirow Tuban
by: Saeful Mizan
Published: (2019-07-01)

Application of Phi (<italic>Φ</italic>), the Golden Ratio, in Computing: A Systematic Review
by: M. Akhtaruzzaman, et al.
Published: (2025-01-01)

HIF-1α promotes kidney organoid vascularization and applications in disease modeling
by: Kexin Peng, et al.
Published: (2023-11-01)

The $\phi$-order of solutions of linear differential equations in the unit disc
by: Lipeng Xiao
Published: (2013-02-01)

Precision Medicine in Erythropoietin Deficiency and Treatment Resistance: A Novel Approach to Management of Anaemia in Chronic Kidney Disease
by: Nava Yugavathy, et al.
Published: (2023-08-01)

Adsorption of Metolachlor and Its Transformation Products, ESA and OXA, on Activated Carbons
by: Alicia Gomis-Berenguer, et al.
Published: (2021-08-01)

Written Tasks through ESA Lesson Planning: Their Impact on Speaking Skill of Iranian EFL Learners
by: Hadi Mokarram
Published: (2023-06-01)

Pertussis Immunization and Convulsions
by: J Gordon Millichap
Published: (1988-06-01)

Relations between Sensory Responsiveness and Features of Autism in Children
by: Jacob I. Feldman, et al.
Published: (2020-10-01)